investigated whether adding the aldosterone receptor antagonist spironolactone to renin–angiotensin system inhibition improved proteinuria in patients with diabetic nephropathy. Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback